Qingdao Vland Biotech (SHSE:603739) Stock Falls 18% in Past Week as Five-year Earnings and Shareholder Returns Continue Downward Trend

Generally speaking long term investing is the way to go. But along the way some stocks are going to perform badly. To wit, the Qingdao Vland Biotech INC. (SHSE:603739) share price managed to fall 60

Simply Wall StApr 16 22:03 ET

Blue Bio (603739.SH): No weight loss related probiotics

Gelonghui, Feb. 19: Weilan Biotech (603739.SH) said on the investor interactive platform that up to now, the company has no probiotics related to weight loss.

Gelonghui FinanceFeb 19 05:03 ET

Qingdao Vland Biotech INC.'s (SHSE:603739) P/E Is On The Mark

Qingdao Vland Biotech INC.'s (SHSE:603739) price-to-earnings (or "P/E") ratio of 41.2x might make it look like a sell right now compared to the market in China, where around half of the companies hav

Simply Wall StJan 24 17:20 ET

Blue Bio (603739.SH): Obtained a new veterinary drug registration certificate

On January 19, Ge Longhui (603739.SH) announced that according to the “Veterinary Drug Administration Regulations” and the “Veterinary Drug Registration Measures”, after review by the Ministry of Agriculture and Rural Affairs, it was approved by Qingdao Weilan Biology Co., Ltd. and its wholly-owned subsidiaries Qingdao Health Insurance National Engineering Technology Research Center Co., Ltd. and Qingdao Kangdian Animal Pharmaceutical Co., Ltd. as three new veterinary drugs, and recently announced the issuance of the “New Veterinary Drug Registration Certificate”.

Gelonghui FinanceJan 19 02:34 ET

Weilan Biotech (603739.SH): Wholly-owned subsidiary obtains a new veterinary drug registration certificate

On January 2, Gelonghui Biotech (603739.SH) announced that after review by the Ministry of Agriculture and Rural Affairs, it approved the “Little Goose Fever Freeze-dried Egg Yolk Antibody” jointly declared by Qingdao Weilan Animal Health Group Co., Ltd., a wholly-owned subsidiary of Qingdao Weilan Biology Co., Ltd. and other organizations, as three new types of new veterinary drugs, and recently announced the issuance of the “New Veterinary Drug Registration Certificate”.

Gelonghui FinanceJan 2 02:38 ET

These 4 Measures Indicate That Qingdao Vland Biotech (SHSE:603739) Is Using Debt Reasonably Well

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' It's only natural to consider a company's balance sheet wh

Simply Wall StDec 26, 2023 20:20 ET